Search every modern research compound
Need dossiers on emerging incretins, mitochondrial peptides, or bespoke analogs? Query the Anubis registry and launch a detail page instantly.
Browse by modality
Compound families
Shortcuts into the highest-signal clusters across peptides, incretins, neuropeptides, and mitochondrial programs.
55518 dossiers
Pharmaceutical
FDA-approved therapeutic agents across diverse pharmacological categories.
184 dossiers
Thyroid
Antithyroid agents for hyperthyroidism and thyroid storm.
37 dossiers
Insulin
Compounds classified in the Insulin family.
666 dossiers
Electrolyte
Mineral supplements for potassium, magnesium, and electrolyte balance restoration.
1147 dossiers
Antibiotic
Antimicrobial agents targeting bacterial infections across respiratory, systemic, and localized sites.
240 dossiers
Corticosteroid
Glucocorticoid anti-inflammatory agents for autoimmune, allergic, and inflammatory conditions.
28 dossiers
Antidepressant
Mood-elevating agents modulating monoamine neurotransmitter systems.
698 dossiers
Vitamin
Essential micronutrients for metabolic function and deficiency prevention.
4 dossiers
Prodrug
Compounds classified in the Prodrug family.
104 dossiers
Antifungal
Azole and echinocandin antifungals for systemic and localized fungal infections.
124 dossiers
Anesthetic
Local and general anesthetics for surgical procedures and pain management.
47 dossiers
PPI
Proton pump inhibitors reducing gastric acid for GERD and ulcer treatment.
147 dossiers
NSAID
Non-steroidal anti-inflammatory drugs blocking cyclooxygenase for pain and inflammation control.
18 dossiers
Psychedelic
Compounds classified in the Psychedelic family.
3 dossiers
Entactogen
Compounds classified in the Entactogen family.
182 dossiers
Hormone
Endocrine modulators including estrogens, androgens, and pituitary hormones.
39 dossiers
Antihistamine
H1 receptor antagonists for allergic rhinitis, urticaria, and motion sickness.
8 dossiers
Amino Acid
Compounds classified in the Amino Acid family.
65 dossiers
Antiviral
Agents inhibiting viral replication for HIV, hepatitis, influenza, and herpes infections.
109 dossiers
Antipsychotic
Dopamine and serotonin receptor antagonists for schizophrenia and bipolar disorder management.
51 dossiers
Chemotherapy
Cytotoxic agents targeting rapidly dividing cells for cancer treatment.
94 dossiers
Kinase Inhibitor
Small molecule tyrosine kinase blockers for targeted cancer therapy and inflammatory conditions.
12 dossiers
SARM
Compounds classified in the SARM family.
13 dossiers
Superfood
Compounds classified in the Superfood family.
1 dossiers
Alcohol Treatment
Compounds classified in the Alcohol Treatment family.
201 dossiers
Supplement
Nutritional supplements including minerals, amino acids, and metabolic cofactors.
3 dossiers
Leukotriene Inhibitor
Cysteinyl leukotriene receptor blockers for asthma and allergies.
77 dossiers
Bronchodilator
Beta-2 agonists and anticholinergics for asthma and COPD airway management.
115 dossiers
Anticonvulsant
Anti-epileptic compounds stabilizing neuronal membranes and modulating ion channels.
27 dossiers
Nootropic
Cognitive enhancers modulating acetylcholine, glutamate, and neurotrophic pathways.
16 dossiers
Laxative
Osmotic and stimulant agents for constipation and bowel preparation.
119 dossiers
Monoclonal Antibody
Engineered antibodies targeting specific antigens for cancer, autoimmune, and inflammatory diseases.
4 dossiers
Thrombolytic
Clot-dissolving agents for acute stroke, myocardial infarction, and pulmonary embolism intervention.
94 dossiers
Opioid
CNS depressants binding opioid receptors for acute pain management and anesthesia protocols.
23 dossiers
Calcium Channel Blocker
L-type calcium channel antagonists for hypertension and angina control.
14 dossiers
Oncology
Targeted therapies and immunomodulators engineered for precision cancer treatment and tumor suppression.
13 dossiers
PDE5 Inhibitor
Phosphodiesterase-5 blockers increasing cGMP for erectile dysfunction and pulmonary hypertension.
2 dossiers
ADHD Stimulant
Compounds classified in the ADHD Stimulant family.
26 dossiers
Anabolic Steroid
Compounds classified in the Anabolic Steroid family.
22 dossiers
Beta Blocker
Adrenergic receptor blockers for hypertension, arrhythmia, and heart failure.
17 dossiers
GLP-1 Agonist
Incretin mimetics engineered for glycemic control, appetite suppression, and cardiometabolic optimization.
84 dossiers
Antidiabetic
Glucose-regulating compounds for type 1 and type 2 diabetes metabolic stabilization.
2 dossiers
Eugeroic
Compounds classified in the Eugeroic family.
31 dossiers
Stimulant
CNS activators enhancing dopamine and norepinephrine for focus, alertness, and ADHD management.
26 dossiers
Immunosuppressant
Calcineurin and mTOR inhibitors for transplant rejection and autoimmune diseases.
101 dossiers
Contraceptive
Hormonal agents for pregnancy prevention and menstrual cycle regulation.
3 dossiers
Decongestant
Compounds classified in the Decongestant family.
18 dossiers
Anticoagulant
Blood thinning agents preventing clot formation for cardiovascular and thrombotic risk management.
9 dossiers
Antiplatelet
Platelet aggregation inhibitors for stroke and cardiovascular prevention.
100 dossiers
Diuretic
Renal agents promoting sodium and water excretion for hypertension and edema.
12 dossiers
Antiemetic
Anti-nausea agents blocking 5-HT3 and dopamine receptors for chemotherapy-induced vomiting.
10 dossiers
Antioxidant
Compounds classified in the Antioxidant family.
48 dossiers
Benzodiazepine
GABA-A positive allosteric modulators for anxiety, seizure, and sleep disorders.
20 dossiers
ACE Inhibitor
Angiotensin-converting enzyme blockers for hypertension and heart failure management.
28 dossiers
Statin
HMG-CoA reductase inhibitors lowering LDL cholesterol for cardiovascular risk reduction.
14 dossiers
Sulfonylurea
Insulin secretagogues stimulating pancreatic beta cells for diabetes.
6 dossiers
Sleep Aid
Sedative-hypnotics modulating GABA or melatonin pathways for insomnia treatment.
9 dossiers
Adaptogen
Compounds classified in the Adaptogen family.
31 dossiers
ARB
Angiotensin II receptor blockers for hypertension and diabetic nephropathy protection.
10 dossiers
Rare Disease
Orphan drug therapeutics addressing genetic and ultra-rare conditions with precision mechanisms.
37 dossiers
Aldosterone Antagonist
Mineralocorticoid receptor blockers for heart failure and hypertension.
31 dossiers
Peptide
Peptide therapeutics accelerating tissue remodeling, neural recalibration, and metabolic control.
10 dossiers
Growth Factor
Hematopoietic stimulators driving blood cell production and recovery protocols.
33 dossiers
Herbal
Compounds classified in the Herbal family.
3 dossiers
Anticholinergic
Muscarinic receptor blockers for COPD, overactive bladder, and motion sickness.
19 dossiers
Prostaglandin
Eicosanoid analogs for glaucoma, labor induction, and gastroprotection.
5 dossiers
5-Alpha Reductase Inhibitor
DHT blockers for benign prostatic hyperplasia and hair loss.
26 dossiers
H2 Blocker
Histamine-2 receptor antagonists reducing gastric acid secretion.
22 dossiers
Inhaled Steroid
Compounds classified in the Inhaled Steroid family.
35 dossiers
Muscle Relaxant
Skeletal muscle relaxants for acute musculoskeletal pain and spasm relief.
1 dossiers
Antiseptic
Compounds classified in the Antiseptic family.
7 dossiers
Barbiturate
GABA-A agonists for anesthesia, seizures, and insomnia (controlled substances).
12 dossiers
SGLT2 Inhibitor
Sodium-glucose cotransporter blockers for diabetes and heart failure.
3 dossiers
Probiotic
Compounds classified in the Probiotic family.
4 dossiers
Bone Therapy
Anabolic agents promoting bone formation for osteoporosis.
2 dossiers
Opioid Treatment
Compounds classified in the Opioid Treatment family.
3 dossiers
Anxiolytic
Compounds classified in the Anxiolytic family.
1 dossiers
Antipruritic
Compounds classified in the Antipruritic family.
11 dossiers
Mineral
Compounds classified in the Mineral family.
29 dossiers
Cannabinoid
Compounds classified in the Cannabinoid family.
2 dossiers
PPAR Agonist
Compounds classified in the PPAR Agonist family.
3 dossiers
Protein
Compounds classified in the Protein family.
9 dossiers
SSRI
Selective serotonin reuptake inhibitors for depression, anxiety, and mood disorder stabilization.
6 dossiers
Mushroom
Compounds classified in the Mushroom family.
2 dossiers
SSRI Antidepressant
Compounds classified in the SSRI Antidepressant family.
1 dossiers
Beta-2 Agonist
Compounds classified in the Beta-2 Agonist family.
1 dossiers
Fertility
Compounds classified in the Fertility family.
1 dossiers
Stool Softener
Compounds classified in the Stool Softener family.
5 dossiers
Racetam
Compounds classified in the Racetam family.
1 dossiers
Topical Steroid
Compounds classified in the Topical Steroid family.
5 dossiers
Digestive Enzyme
Pancreatic enzyme replacements for exocrine insufficiency and malabsorption syndromes.
5 dossiers
SNRI
Serotonin-norepinephrine reuptake inhibitors for depression, anxiety, and neuropathic pain.
11 dossiers
DPP-4 Inhibitor
Dipeptidyl peptidase-4 blockers enhancing incretin hormones for diabetes.
2 dossiers
Cold Medicine
Compounds classified in the Cold Medicine family.
14 dossiers
Dissociative
Compounds classified in the Dissociative family.
2 dossiers
Bisphosphonate
Osteoclast inhibitors for osteoporosis and bone metastases.
2 dossiers
GLP-1
Next-gen incretin analogs tuned for aggressive weight normalization and glycemic stability.
2 dossiers
SNRI Antidepressant
Compounds classified in the SNRI Antidepressant family.
6 dossiers
Biologic
Monoclonal antibodies and fusion proteins targeting autoimmune, inflammatory, and immunological disorders.
3 dossiers
Analgesic
Pain-relieving compounds acting on peripheral and central pain pathways.
5 dossiers
Respiratory
Bronchodilators and anti-inflammatory agents for asthma, COPD, and respiratory distress management.
3 dossiers
Depressant
Compounds classified in the Depressant family.
1 dossiers
Antiflatulent
Compounds classified in the Antiflatulent family.
2 dossiers
Growth Hormone
Compounds classified in the Growth Hormone family.
2 dossiers
Growth Hormone Secretagogue
Compounds classified in the Growth Hormone Secretagogue family.
2 dossiers
Diabetes
Compounds classified in the Diabetes family.
2 dossiers
CFTR Modulator
Ion channel correctors restoring chloride transport in cystic fibrosis pathology.
1 dossiers
Dissociative/Antidepressant
Compounds classified in the Dissociative/Antidepressant family.
2 dossiers
Opioid-like
Compounds classified in the Opioid-like family.
2 dossiers
Mood Stabilizer
Compounds classified in the Mood Stabilizer family.
2 dossiers
Fiber
Compounds classified in the Fiber family.
3 dossiers
Urological
Agents for overactive bladder, urinary incontinence, and urinary retention.
3 dossiers
Antacid
Compounds classified in the Antacid family.
2 dossiers
Opioid Antagonist
Naloxone and naltrexone reversing opioid effects and treating addiction.
6 dossiers
Meglitinide
Rapid-acting insulin secretagogues for postprandial glucose control.
1 dossiers
Antidiarrheal
Compounds classified in the Antidiarrheal family.
2 dossiers
Thiazolidinedione
PPAR-gamma agonists improving insulin sensitivity in type 2 diabetes.
1 dossiers
Hemorrhoid Treatment
Compounds classified in the Hemorrhoid Treatment family.
1 dossiers
Triple Agonist
Compounds classified in the Triple Agonist family.
1 dossiers
Cough Suppressant
Compounds classified in the Cough Suppressant family.
1 dossiers
Hair Loss
Compounds classified in the Hair Loss family.
1 dossiers
GLP-1 Weight Loss
Compounds classified in the GLP-1 Weight Loss family.
1 dossiers
ED Medication
Compounds classified in the ED Medication family.
2 dossiers
Rev-ErbA Agonist
Compounds classified in the Rev-ErbA Agonist family.
1 dossiers
Thyroid Hormone
Synthetic levothyroxine and analogs for hypothyroidism replacement therapy.
1 dossiers
GLP-1/GIP Agonist
Compounds classified in the GLP-1/GIP Agonist family.
1 dossiers
Sleep/Antidepressant
Compounds classified in the Sleep/Antidepressant family.
1 dossiers
JAK Inhibitor
Small molecule kinase inhibitors modulating inflammatory and autoimmune signaling cascades.
3 dossiers
Thienodiazepine
Compounds classified in the Thienodiazepine family.
9 dossiers
Designer Benzodiazepine
Compounds classified in the Designer Benzodiazepine family.
7 dossiers
Cathinone
Beta-keto amphetamine derivatives with stimulant and entactogenic effects.
10 dossiers
Plant
Compounds classified in the Plant family.
6 dossiers
Phenethylamine
Amphetamine-class compounds and derivatives acting on monoamine neurotransmitter systems.
6 dossiers
Amphetamine
Compounds classified in the Amphetamine family.
4 dossiers
Arylcyclohexylamine
Dissociative anesthetics blocking NMDA receptors for analgesia and anesthesia.
7 dossiers
Tryptamine
Indole alkaloids derived from tryptophan with serotonergic psychoactive properties.
1 dossiers
Phenmetrazine
Compounds classified in the Phenmetrazine family.
1 dossiers
Alkaloid
Nitrogen-containing organic compounds of plant origin with diverse pharmacological activities.
1 dossiers
Z-Drug
Compounds classified in the Z-Drug family.
4 dossiers
Inhalant
Compounds classified in the Inhalant family.
2 dossiers
Acid
Compounds classified in the Acid family.
8 dossiers
Solvent
Compounds classified in the Solvent family.
1 dossiers
Salt
Compounds classified in the Salt family.
1 dossiers
Base
Compounds classified in the Base family.
2 dossiers
Reagent
Compounds classified in the Reagent family.
1 dossiers
Catalyst
Compounds classified in the Catalyst family.
2 dossiers
Oxidizer
Compounds classified in the Oxidizer family.
7 dossiers
Precursor
Compounds classified in the Precursor family.
4 dossiers
Excipient
Compounds classified in the Excipient family.
5 dossiers
Gas
Compounds classified in the Gas family.
1 dossiers
Neuropeptide
Neuromodulatory signals engineered for cognitive resilience and appetite governance.
Governance overlays
Risk-calibrated cohorts
Pre-filter dossiers by operational risk so compliance teams can fast-track reviews.